Unify Financial Advisors’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$508K Sell
8,700
-102
-1% -$6.02K 0.47% 55
2026
Q2
$494K Sell
8,802
-35
-0.4% -$1.82K 0.46% 56
2026
Q1
$424K Sell
8,837
-1,385
-14% -$60.7K 0.44% 63
2025
Q4
$395K Buy
+10,222
New +$390K 0.41% 66

Other funds holding RPRX

Unify Financial Advisors's RPRX Position: Q3 2026 in Review

Unify Financial Advisors reduced its Royalty Pharma (RPRX) stake by 1.2% in Q3 2026, selling an estimated $6.02K and leaving 8,700 shares worth $508K. The position accounts for 0.47% of the portfolio, ranked #55.

Unify Financial Advisors first reported a position in RPRX in Q4 2025 and has held it in 4 quarters since. 707 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Unify Financial Advisors held 8,700 shares of Royalty Pharma worth $508K as of Q3 2026.
  • Unify Financial Advisors sold 102 Royalty Pharma shares in Q3 2026, an estimated $6.02K.
  • Royalty Pharma made up 0.47% of Unify Financial Advisors's portfolio in Q3 2026, its #55 holding.
  • Unify Financial Advisors first reported a position in Royalty Pharma in Q4 2025 and has held it in 4 quarters since.
  • 707 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Unify Financial Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.